New Business Ethiopia

Leishmaniasis patients in Eastern Africa may soon benefit from a new drug set to be developed by collaboration of Novartis, one of the biggest pharmaceuticals company and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organization.

The third round of Africa Business Forum scheduled in Addis Ababa, Ethiopia next month is set to focus on investing in people, planet and prosperity.

Ethiopia’s export performance which has been declining since 2012, has dropped by $170 million for the fiscal year concluded July 7, 2019 as compared to the previous year.

African continent can create jobs to 60 million in drug industries if the continent invest in the manufacturing of pharmaceuticals products locally, says UN official.